South-East Asia ‘must clamp down on fake drugs’ [[Burma]]
Andrew Witty, the chief executive of GlaxoSmithKline, has waded into the
debate on fake pharmaceuticals by urging governments in South-East Asia to
clamp down on counterfeiters.
Mr Witty told The Times that more needed to be done to punish those who
are involved with producing and selling dangerous fake treatments.
By